From: A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefits
Liver
Skeletal muscle
Adipose
Brain
Time (h)
1
7
% inhibition with CNX-010-49
58 ± 2
24 ± 6
41 ± 4
44 ± 5
38 ± 7
42 ± 5
0